• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

体育活动在非酒精性和代谢功能障碍相关脂肪性肝病中的作用

The Role of Physical Activity in Nonalcoholic and Metabolic Dysfunction Associated Fatty Liver Disease.

作者信息

von Loeffelholz Christian, Roth Johannes, Coldewey Sina M, Birkenfeld Andreas L

机构信息

Department of Anesthesiology and Intensive Care Medicine, Jena University Hospital, 07747 Jena, Germany.

Septomics Research Center, Jena University Hospital, 07747 Jena, Germany.

出版信息

Biomedicines. 2021 Dec 7;9(12):1853. doi: 10.3390/biomedicines9121853.

DOI:10.3390/biomedicines9121853
PMID:34944668
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8698784/
Abstract

Sedentary behavior constitutes a pandemic health threat contributing to the pathophysiology of obesity and type 2 diabetes (T2D). Sedentarism is further associated with liver disease and particularly with nonalcoholic/metabolic dysfunction associated fatty liver disease (NAFLD/MAFLD). Insulin resistance (IR) represents an early pathophysiologic key element of NAFLD/MAFLD, prediabetes and T2D. Current treatment guidelines recommend regular physical activity. There is evidence, that physical exercise has impact on a variety of molecular pathways, such as AMP-activated protein kinase and insulin signaling as well as glucose transporter 4 translocation, modulating insulin action, cellular substrate flow and in particular ectopic lipid and glycogen storage in a positive manner. Therefore, physical exercise can lead to substantial clinical benefit in persons with diabetes and/or NAFLD/MAFLD. However, experience from long term observational studies shows that the patients' motivation to exercise regularly appears to be a major limitation. Strategies to integrate everyday physical activity (i.e., nonexercise activity thermogenesis) in lifestyle treatment schedules might be a promising approach. This review aggregates evidence on the impact of regular physical activity on selected molecular mechanisms as well as clinical outcomes of patients suffering from IR and NAFLD/MAFLD.

摘要

久坐行为构成了一种全球性的健康威胁,会导致肥胖和2型糖尿病(T2D)的病理生理过程。久坐不动还与肝脏疾病相关,尤其是与非酒精性/代谢功能障碍相关脂肪性肝病(NAFLD/MAFLD)有关。胰岛素抵抗(IR)是NAFLD/MAFLD、糖尿病前期和T2D早期病理生理的关键因素。当前的治疗指南推荐定期进行体育锻炼。有证据表明,体育锻炼会对多种分子途径产生影响,如AMP激活的蛋白激酶和胰岛素信号传导以及葡萄糖转运蛋白4易位,以积极的方式调节胰岛素作用、细胞底物流动,特别是异位脂质和糖原储存。因此,体育锻炼可给糖尿病和/或NAFLD/MAFLD患者带来显著的临床益处。然而,长期观察研究的经验表明,患者定期锻炼的积极性似乎是一个主要限制因素。将日常体力活动(即非运动活动产热)纳入生活方式治疗计划的策略可能是一种有前景的方法。这篇综述汇总了关于定期体育锻炼对IR和NAFLD/MAFLD患者选定分子机制以及临床结局影响的证据。

相似文献

1
The Role of Physical Activity in Nonalcoholic and Metabolic Dysfunction Associated Fatty Liver Disease.体育活动在非酒精性和代谢功能障碍相关脂肪性肝病中的作用
Biomedicines. 2021 Dec 7;9(12):1853. doi: 10.3390/biomedicines9121853.
2
Nonalcoholic fatty liver disease should be considered for treatment allocation in standard management algorithms for type 2 diabetes.非酒精性脂肪性肝病应在 2 型糖尿病的标准管理算法中考虑作为治疗分配的因素。
Diabetes Metab Syndr. 2020 Nov-Dec;14(6):2233-2239. doi: 10.1016/j.dsx.2020.11.015. Epub 2020 Nov 19.
3
Nonalcoholic Fatty Liver Disease: An Emerging Modern-Day Risk Factor for Cardiovascular Disease.非酒精性脂肪性肝病:一种新出现的现代心血管疾病风险因素。
Cureus. 2022 May 30;14(5):e25495. doi: 10.7759/cureus.25495. eCollection 2022 May.
4
Nonalcoholic fatty liver disease or metabolic dysfunction-associated fatty liver disease diagnoses and cardiovascular diseases: From epidemiology to drug approaches.非酒精性脂肪性肝病或代谢相关脂肪性肝病诊断与心血管疾病:从流行病学到药物治疗方法。
Eur J Clin Invest. 2021 Jul;51(7):e13519. doi: 10.1111/eci.13519. Epub 2021 Mar 2.
5
Fetuin-B links nonalcoholic fatty liver disease to type 2 diabetes via inducing insulin resistance: Association and path analyses.胎球蛋白-B 通过诱导胰岛素抵抗将非酒精性脂肪性肝病与 2 型糖尿病联系起来:关联和路径分析。
Cytokine. 2018 Aug;108:145-150. doi: 10.1016/j.cyto.2018.03.023. Epub 2018 Mar 30.
6
Prevalence of prediabetes and diabetes and metabolic profile of patients with nonalcoholic fatty liver disease (NAFLD).非酒精性脂肪性肝病(NAFLD)患者的糖尿病前期和糖尿病患病率及代谢特征。
Diabetes Care. 2012 Apr;35(4):873-8. doi: 10.2337/dc11-1849. Epub 2012 Feb 28.
7
The Gut Microbiome and Ferroptosis in MAFLD.非酒精性脂肪性肝病中的肠道微生物群与铁死亡
J Clin Transl Hepatol. 2023 Feb 28;11(1):174-187. doi: 10.14218/JCTH.2022.00136. Epub 2022 Jul 14.
8
Metabolic Dysfunction-associated Fatty Liver Disease and Mortality Among Chinese Adults: a Prospective Cohort Study.代谢相关脂肪性肝病与中国成年人死亡风险的前瞻性队列研究。
J Clin Endocrinol Metab. 2022 Jan 18;107(2):e745-e755. doi: 10.1210/clinem/dgab644.
9
Metabolic dysfunction-associated fatty liver disease: current therapeutic strategies.代谢功能障碍相关脂肪性肝病:当前的治疗策略
Front Nutr. 2024 Mar 19;11:1355732. doi: 10.3389/fnut.2024.1355732. eCollection 2024.
10
From Nonalcoholic Fatty Liver Disease (NAFLD) to Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD)-New Terminology in Pediatric Patients as a Step in Good Scientific Direction?从非酒精性脂肪性肝病(NAFLD)到代谢功能障碍相关脂肪性肝病(MAFLD)——儿科患者的新术语,是朝着良好科学方向迈出的一步吗?
J Clin Med. 2021 Mar 1;10(5):924. doi: 10.3390/jcm10050924.

引用本文的文献

1
Retatrutide-A Game Changer in Obesity Pharmacotherapy.瑞他鲁肽——肥胖症药物治疗的变革者。
Biomolecules. 2025 May 30;15(6):796. doi: 10.3390/biom15060796.
2
Fatty Liver and Hyperuricemia in Workers: Combined Effects on Metabolic Dysfunction and the Role of Lifestyle Factors.工人中的脂肪肝和高尿酸血症:对代谢功能障碍的联合影响及生活方式因素的作用
Metabolites. 2025 May 9;15(5):318. doi: 10.3390/metabo15050318.
3
Mediational role of metabolic syndrome between physical activity, sedentary behavior and non-alcoholic fatty liver disease: a cross-sectional study.

本文引用的文献

1
Evidence-based clinical practice guidelines for nonalcoholic fatty liver disease/nonalcoholic steatohepatitis 2020.2020 年非酒精性脂肪性肝病/非酒精性脂肪性肝炎临床实践循证指南。
J Gastroenterol. 2021 Nov;56(11):951-963. doi: 10.1007/s00535-021-01796-x. Epub 2021 Sep 17.
2
A Narrative Review on the Role of AMPK on De Novo Lipogenesis in Non-Alcoholic Fatty Liver Disease: Evidence from Human Studies.AMPK 在非酒精性脂肪性肝病从头合成脂肪中的作用的叙事性综述:来自人体研究的证据。
Cells. 2021 Jul 19;10(7):1822. doi: 10.3390/cells10071822.
3
Non-Obese MAFLD Is Associated with Colorectal Adenoma in Health Check Examinees: A Multicenter Retrospective Study.
代谢综合征在身体活动、久坐行为与非酒精性脂肪性肝病之间的中介作用:一项横断面研究
BMC Public Health. 2025 May 6;25(1):1661. doi: 10.1186/s12889-025-22925-8.
4
Prevalence of MAFLD in the U.S. based on NHANES 2009-2018: differences in demographic characteristics, physical indices and lifestyle conditions.基于2009 - 2018年美国国家健康与营养检查调查(NHANES)的美国代谢功能障碍相关脂肪性肝病(MAFLD)患病率:人口统计学特征、身体指标和生活方式状况的差异
BMC Gastroenterol. 2025 May 2;25(1):329. doi: 10.1186/s12876-025-03956-2.
5
Evaluating the RESET care program: Advancing towards scalable and effective healthcare solutions for metabolic dysfunction-associated liver disease.评估RESET护理计划:迈向针对代谢功能障碍相关肝病的可扩展且有效的医疗保健解决方案。
World J Hepatol. 2025 Apr 27;17(4):105254. doi: 10.4254/wjh.v17.i4.105254.
6
Hidden in the Fat: Unpacking the Metabolic Tango Between Metabolic Dysfunction-Associated Steatotic Liver Disease and Metabolic Syndrome.隐匿于脂肪之中:解析代谢功能障碍相关脂肪性肝病与代谢综合征之间的代谢探戈
Int J Mol Sci. 2025 Apr 7;26(7):3448. doi: 10.3390/ijms26073448.
7
[Different Types of Obesity Play a Modifying Role in the Association Between Physical Activity and Metabolic Dysfunction-Associated Fatty Liver Disease].[不同类型的肥胖在体力活动与代谢功能障碍相关脂肪性肝病的关联中起调节作用]
Sichuan Da Xue Xue Bao Yi Xue Ban. 2025 Jan 20;56(1):149-155. doi: 10.12182/20250160108.
8
Life's Crucial 9 and NAFLD from association to SHAP-interpreted machine learning predictions.生命关键的9要素与非酒精性脂肪性肝病:从关联到SHAP解释的机器学习预测
Sci Rep. 2025 Mar 18;15(1):9384. doi: 10.1038/s41598-025-92777-0.
9
Metabolic dysfunction-associated fatty liver disease increases risk of chronic kidney disease: a systematic review and meta-analysis.代谢功能障碍相关脂肪性肝病增加慢性肾脏病风险:一项系统评价和荟萃分析
eGastroenterology. 2023 Aug 7;1(1):e100005. doi: 10.1136/egastro-2023-100005. eCollection 2023 Jun.
10
Evidence summary of lifestyle interventions in adults with metabolic dysfunction-associated steatotic liver disease.成人代谢功能障碍相关脂肪性肝病生活方式干预的证据总结
Front Nutr. 2025 Jan 6;11:1421386. doi: 10.3389/fnut.2024.1421386. eCollection 2024.
非肥胖 MAFLD 与健康检查受检者的结直肠腺瘤相关:一项多中心回顾性研究。
Int J Mol Sci. 2021 May 22;22(11):5462. doi: 10.3390/ijms22115462.
4
Moderate-Intensity Aerobic vs Resistance Exercise and Dietary Modification in Patients With Nonalcoholic Fatty Liver Disease: A Randomized Clinical Trial.非酒精性脂肪性肝病患者的中等强度有氧运动与抗阻运动和饮食调整的随机临床试验。
Clin Transl Gastroenterol. 2021 Mar;12(3):e00316. doi: 10.14309/ctg.0000000000000316.
5
Excessive exercise training causes mitochondrial functional impairment and decreases glucose tolerance in healthy volunteers.过度运动训练会导致健康志愿者的线粒体功能障碍和葡萄糖耐量降低。
Cell Metab. 2021 May 4;33(5):957-970.e6. doi: 10.1016/j.cmet.2021.02.017. Epub 2021 Mar 18.
6
Tumor Incidence in Patients with Non-Alcoholic Fatty Liver Disease.非酒精性脂肪性肝病患者的肿瘤发病率。
Dtsch Arztebl Int. 2020 Oct 23;117(43):719-724. doi: 10.3238/arztebl.2020.0719.
7
Contribution of sarcopenia and physical inactivity to mortality in people with non-alcoholic fatty liver disease.肌肉减少症和身体活动不足对非酒精性脂肪性肝病患者死亡率的影响。
JHEP Rep. 2020 Aug 15;2(6):100171. doi: 10.1016/j.jhepr.2020.100171. eCollection 2020 Dec.
8
Nonexercise Activity Thermogenesis-Induced Energy Shortage Improves Postprandial Lipemia and Fat Oxidation.非运动活动产热诱导的能量短缺改善餐后血脂异常和脂肪氧化。
Life (Basel). 2020 Aug 27;10(9):166. doi: 10.3390/life10090166.
9
Nonalcoholic Fatty Liver Disease and Alcoholic Liver Disease are Major Drivers of Liver Mortality in the United States.非酒精性脂肪性肝病和酒精性肝病是美国肝脏死亡率的主要驱动因素。
Hepatol Commun. 2020 Apr 4;4(6):890-903. doi: 10.1002/hep4.1510. eCollection 2020 Jun.
10
Association between high dose catecholamine support and liver dysfunction following cardiac surgery.心脏手术后高剂量儿茶酚胺支持与肝功能障碍之间的关联。
J Card Surg. 2020 Jun;35(6):1228-1236. doi: 10.1111/jocs.14555. Epub 2020 Apr 25.